Company Announcements

All company announcements are listed below. To receive them automatically, sign up to our email announcements.
31- March -17 Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplus® download
29- March -17 Genetic Technologies and IndyCar’s Pippa Mann Partner for Second Consecutive Year to Promote BREVAGenplus® download
20- Feb -17 Employee Share Options Issued and Forfeited download
6- Dec-16 Cleansing notice under section 708A the Corporations Act 2001 (Cthdownload
6-Dec-16 Capital Raising Update – Appendix 3B download
2-Dec-16 Genetic Technologies Announces AUD 8.1 million Capital Raising download
29-Nov-16 Exclusive License Agreement To Develop Colorectal Cancer Risk Assessment Test download
23-Nov-16 -16 2016 Annual General Meeting Results  download
23-Nov-16 -16 2016 Annual General Meeting Presentation download
24-Oct-16 Notice of 2016 Annual General Meeting and Sample Proxy download
3-Oct -16 Genetic Technologies Launches BREVAGenplus® Marketing Program
Around Susan G. Komen®’s Race for the Cure® Events download
30-Aug-2016 Appendix 4E & Financial Report 2016 download
30-Aug-2016 Appendix 4G and Corporate Governance Statement 2016 download
22 June -16 Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann Update BREVAGenplus® Marketing Partnership  download
21 June -16 Appointment of Senior Medical Director download
4-May -16 Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann to
Ring Nasdaq Stock Market Closing Bell on May 6th, 2016 download
6-April -16 Appendix 3B download
6-April -16 Lapse of Share Options download
22-Feb -16 Genetic Technologies and IndyCar’s Pippa Mann Announce Partnership to
Promote BREVAGenplus® download
5-Feb -16 Settlement and Release Agreement with Hendrix Genetics B.V. download
13-Jan -16 Changes to Company Secretary download
21-Dec-15 Genetic Technologies Announces Publication of Key scientific Validation Results in Support of BREVAGenplus download
15-Dec-15 Appendix 3Y download
15-Dec-15 Appendix 3B download
25-Nov -15 Results from 2015 Annual General Meeting download
25-Nov -15 2015 Annual General Meeting download
23-Nov-15 Genetic Technologies Announces Publication Validating BREVAGenplus  Testing for African-American and Hispanic Women download
02-Nov-15 Appendix 3Y download
29-Oct-15 Appendix 4C download
27-Oct-15 Notice of AGM and Sample Proxy download
06-Oct -15 CFO Transition download
24-Sep-15 Appendix 4G and Corporate Governance Statement download
28-Aug-15 Lapse of Options download
06-Aug-15 US Patent Office Grants Key BREVAGENplus® download
31-July-15 Appendix 4C download
23-July-15 Appendix 3B download
14-July-15 Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review Publication Initiatives download
09-July-15 Appointment of Joint Company Secretary download
15-June-15 Appointment of Chief Financial Officer download
12-June-15 Appointment of Executive Director download
29-May-15 Genetic Technologies supports research findings: Clinical validation is needed for gene-panel sequencing associated with hereditary breast cancer risk  download
04-May-15 Second of Two Nasdaq Deficiencies Successfully Remediated  download
23-April-15 Appendix 3Y  download
20-April-15 Additional Breast Health Centres To Begin Offering BREVAGENplus download
01-April-15 Appendix 3Y download

Subscribe to Company Announcements

Full name (required)


Email address (required)

Confirm email address (required)

Phone Number


Enquiry details